Evidence map›Paper›PMID 30192549›Full record

ArticleThe journal of physical chemistry letters2018

Cholesterol Flip-Flop Impacts Domain Registration in Plasma Membrane Models.

Sebastian Thallmair, Helgi I Ingólfsson, Siewert J Marrink

Abstract read
In one paragraph

Article in The journal of physical chemistry letters, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Dual Resolution Membrane Simulations Using Virtual Sites.The journal of physical chemistry. B · 2020
    Article
  12. Article
  13. Article
  14. Interleaflet Coupling of Lipid Nanodomains - Insights FromFrontiers in cell and developmental biology · 2020
    Review
  15. Article
  16. Nanoscale dynamics of cholesterol in the cell membrane.The Journal of biological chemistry · 2019
    Article
  17. Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sebastian ThallmairGroningen Biomolecular Sciences and Biotechnology Institute and The Zernike Institute for Advanced Material , University of Groningen , Nijenborgh 7 , 9747 AG Groningen , Netherlands.ORCID http://orcid.org/0000-0002-3396-5840
Helgi I IngólfssonGroningen Biomolecular Sciences and Biotechnology Institute and The Zernike Institute for Advanced Material , University of Groningen , Nijenborgh 7 , 9747 AG Groningen , Netherlands.ORCID http://orcid.org/0000-0002-7613-9143
Siewert J MarrinkGroningen Biomolecular Sciences and Biotechnology Institute and The Zernike Institute for Advanced Material , University of Groningen , Nijenborgh 7 , 9747 AG Groningen , Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The plasma membrane is a highly complex multicomponent system that is central to the functioning of cells. Cholesterol, a key lipid component of the plasma membrane, promotes the formation of nanodomains. These nanodomains are often correlated across the two membrane leaflets, but the underlying physical mechanism remains unclear. Using coarse-grained molecular dynamics simulations, we investigate the influence of cholesterol flip-flop on membrane properties, in particular, the interleaflet coupling of cholesterol-enriched domains. We show that the cholesterol density correlation between the leaflets of an average mammalian plasma membrane is significantly reduced by suppressing interleaflet cholesterol population. Our results suggest an amplifying role of cholesterol in signal transduction across the leaflets.

Identifiers

PMID30192549
PMCPMC6151656

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.